| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 225 | 6.730 | 7.457 | 7.937 | 2.911 | 0 | 1.941 | 0 | 1.243 | 2.952 |
| Total Income - EUR | 225 | 38.320 | 10.884 | 14.747 | 20.600 | 5.511 | 7.595 | 258 | 5.702 | 2.952 |
| Total Expenses - EUR | 218 | 3.512 | 5.343 | 13.273 | 9.309 | 4.983 | 10.508 | 511 | 839 | 2.486 |
| Gross Profit/Loss - EUR | 7 | 34.808 | 5.541 | 1.473 | 11.291 | 528 | -2.913 | -253 | 4.863 | 466 |
| Net Profit/Loss - EUR | 0 | 34.606 | 5.372 | 1.393 | 11.223 | 528 | -2.973 | -253 | 4.085 | 391 |
| Employees | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ilesebatib Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 3.965 | 6.843 | 9.831 | 8.700 | 8.046 | 8.071 | 8.046 | 8.001 |
| Current Assets | 270 | 36.429 | 42.775 | 36.761 | 43.421 | 44.014 | 40.595 | 40.407 | 45.147 | 44.587 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 540 | 0 |
| Receivables | 0 | 0 | 2.802 | 0 | 0 | 0 | 0 | 0 | 36.389 | 40.207 |
| Cash | 270 | 36.429 | 17.986 | 20.457 | 27.361 | 32.484 | 36.448 | 40.407 | 8.218 | 4.380 |
| Shareholders Funds | 45 | 34.650 | 42.181 | 42.800 | 53.195 | 52.714 | 48.580 | 48.477 | 52.415 | 52.513 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 225 | 1.779 | 4.558 | 804 | 57 | 0 | 61 | 0 | 779 | 75 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Ilesebatib Srl